British Journal of Pharmacology (Free subscription) | yesterday
Tailoring the AAV vector capsid for gene therapy Gene Therapy advance online publication, December 4, 2008. doi:10.1038/gt.2008.170 Authors: L H Vandenberghe, J M Wilson & G Gao
CloningResources.com: Cloning News, (Free subscription) | 4 hours ago
A Canadian and American research group including the team of Dr. Robert Koenekoop from the Research Institute at the Montreal Children's Hospital of the MUHC has just been awarded CA$2.4 million from the Canadian Institutes of Health Research and the Foundation Fighting Blindness Canada. This five-year grant will fund an ambitious research project to develop innovative gene therapies for a...
bioethics.com (Free subscription) | yesterday
Using a harmless virus to insert a corrective gene into mouse blood cells, scientists at St. Jude Children’s Research Hospital have alleviated sickle cell disease pathology. (News-Medical)
British Journal of Pharmacology (Free subscription) | yesterday
Transduction of human neural progenitor cells with foamy virus vectors for differentiation-dependent gene expression Gene Therapy advance online publication, December 4, 2008. doi:10.1038/gt.2008.173 Authors: I Rothenaigner, S Kramer, M Meggendorfer, A Rethwilm & R Brack-Werner
Medical News Today (Free subscription) | yesterday
Using a harmless virus to insert a corrective gene into mouse blood cells, scientists at St. Jude Children's Research Hospital have alleviated sickle cell disease pathology. In their studies, the researchers found that the treated mice showed essentially no difference from normal mice.
Medical News Today (Free subscription) | 5 hours ago
Researchers at Columbia University Medical Center and the State University of New York at Stony Brook (SUNY) have developed a groundbreaking technique to sneak therapeutic genes past the body's defenses, possibly clearing one of the largest hurdles to realizing the potentials of medically altering a patient's DNA.
Newswise (Free subscription) | yesterday
Researchers at Columbia University Medical Center and the State University of New York at Stony Brook (SUNY) have developed a groundbreaking technique to sneak therapeutic genes past the body's defenses, possibly clearing one of the largest hurdles to realizing the potentials of medically altering a patient's DNA.
Genetics and Health (Free subscription) | yesterday
Scientists are used to being cautious. But I was reading this article and I was beside clapping for the science! See, whenever we get very good results from our experiments, we always tell ourselves "let’s test this some more", "let’s confirm this in some other population". Well, let’s. But the results of this new study are so encouraging that we ought to celebrate with virtual champagne! Gene...
British Journal of Pharmacology (Free subscription) | yesterday
Foamy virus as a gene transfer vector to the central nervous system Gene Therapy advance online publication, December 4, 2008. doi:10.1038/gt.2008.171 Authors: A V Caprariello, R H Miller & S M Selkirk
Medical News Today (Free subscription) | yesterday
A Canadian and American research group including the team of Dr. Robert Koenekoop from the Research Institute at the Montreal Children's Hospital of the MUHC has just been awarded $2.4 million from the Canadian Institutes of Health Research (CIHR) and the Foundation Fighting Blindness Canada (FFB). This five-year grant will fund an ambitious research project to develop innovative gene therapies for...
Physorg (Free subscription) | 03/12/2008
Using a harmless virus to insert a corrective gene into mouse blood cells, scientists at St. Jude Children's Research Hospital have alleviated sickle cell disease pathology. In their studies, the researchers found that the treated mice showed essentially no difference from normal mice. Although the scientists caution that applying the gene therapy to humans presents significant...
Red Orbit (Free subscription) | 03/12/2008
New St. Jude treatment alleviates long-term anemia and organ damage in mice and paves the way for human applicationsUsing a harmless virus to insert a corrective gene into mouse blood cells, scientists at St.
Science Daily (Free subscription) | 03/12/2008
Using a harmless virus to insert a corrective gene into mouse blood cells, scientists have alleviated sickle cell disease pathology. In their studies, the researchers found that the treated mice showed essentially no difference from normal mice. Although the scientists caution that applying the gene therapy to humans presents significant technical obstacles, they believe that the new...
Life Science World (Free subscription) | 03/12/2008
[NEWS] New St. Jude treatment alleviates long-term anemia and organ damage in mice and paves the way for human applications MEMPHIS, Tenn., Dec. 3 /PRNewswire-USNewswire/ — Using a harmless virus to insert a corrective gene into mouse blood cells, scientists at St. Jude Children's Research Hospital have alleviated sickle cell disease pathology. In their studies, the researchers found that the...
British Journal of Pharmacology (Free subscription) | 02/12/2008
Antiangiogenic Gene Therapy With Soluble VEGFR-1, -2, and -3 Reduces the Growth of Solid Human Ovarian Carcinoma in Mice Molecular Therapy advance online publication, December 2, 2008. doi:10.1038/mt.2008.258 Authors: Hanna Sallinen, Maarit Anttila, Johanna Narvainen, Jonna Koponen, Kirsi Hamalainen, Ivana Kholova, Tommi Heikura, Pyry Toivanen, Veli-Matti Kosma, Seppo Heinonen,...
